Otros idiomas Lotus Bio-Technology Development Corp.

Acciones

LBTD

US54570R1077

Mercado cerrado - OTC Markets Otros sitios de cotización 19:04:43 10/08/2023			Varia. Cinco días.	Varia. 1 de enero.
0,01 ^USD	-34,64 %		-.--%	-.--%

2023	Lotus Bio-Technology Development Corp. (OTCPK:LBTD) adquirió Pioneer Digital Health, Inc.	CI
2022	BioGnomics Lab, LLC adquirió Boomerangkit.com, LLC de Lotus Bio-Technology Development Corp. (OTCPK:LBTD).	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health	16/02/23
Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.	16/02/23
Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding	23/12/22
Lotus Bio-Technology Development Corp. announced that it expects to receive $0.05 million in funding	14/12/22
Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC	25/10/22
BioGnomics Lab, LLC acquired Boomerangkit.com, LLC from Lotus Bio-Technology Development Corp..	25/10/22
Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint	30/08/22
Lotus Bio Technology Development : Current Report	19/08/22
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change	16/08/22
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Director and Surrendering of 150,000,000 Common Shares to Treasury.	16/08/22
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Zoltan Nagy as Director	16/08/22
Lotus Bio-Technology Development Corp. Announces YTD Revenues And Projections by The Newly Acquired Companies in The Digital Health And Wellness Home Testing Industry.	02/08/22
Lotus Bio-Technology Development Corp. Enters Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Focal Point, Inc. and Boomerangkit.com, LLC.	06/07/22
Lotus Bio-Technology Development Corp. Appoints Hoyt Christopher as CEO	06/07/22
Lotus Bio-Technology Development Corp. acquired Boomerangkit.com, LLC/Focal Point, Inc. from Focal Point, Inc. and Boomerangkit.com, LLC.	06/07/22
Lotus Bio Technology Development : Attorney Letter with Respect to Current Information	30/06/22
Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent	13/04/22
Lotus Bio-Technology Development Corp. entered into a binding letter of intent to acquire Little Jupiter Gold Project in Nevada, USA from AMT Industries Canada Inc.	13/04/22
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)	07/04/21
Lotus Bio-Technology Development Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2017	07/04/21

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Lotus Bio-Technology Development Corp.

Acciones

LBTD

US54570R1077

Otros idiomas

Filtros